UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$288M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$215M |
| 3 |
Tractor Supply
TSCO
|
+$157M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
PayPal
PYPL
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$339M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$244M |
| 3 |
PX
Praxair Inc
PX
|
+$218M |
| 4 |
Meta Platforms (Facebook)
META
|
+$182M |
| 5 |
Adobe
ADBE
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 14.9% |
| 3 | Financials | 14.08% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WCC
1276
WESCO International
WCC
$17.7B
| $2.67M | ﹤0.01% |
55,703
-2,349
| -4% | -$122K |
|
|
CHK
1277
DELISTED
Chesapeake Energy Corporation
CHK
| $2.66M | ﹤0.01% |
6,343
-214
| -3% | -$147K |
|
1278
Glacier Bancorp
GBCI
$6.35B
| $2.66M | ﹤0.01% |
67,200
+3,739
| +6% | +$161K |
|
1279
Bruker
BRKR
$8.14B
| $2.66M | ﹤0.01% |
89,424
-17,954
| -17% | -$567K |
|
1280
Cracker Barrel
CBRL
$1.29B
| $2.65M | ﹤0.01% |
16,596
+657
| +4% | +$108K |
|
|
TWOU
1281
DELISTED
2U Inc
TWOU
| $2.65M | ﹤0.01% |
1,773
+36
| +2% | +$63.3K |
|
1282
Trex
TREX
$5.01B
| $2.64M | ﹤0.01% |
88,944
+10,820
| +14% | +$339K |
|
|
ILPT
1283
Industrial Logistics Properties Trust
ILPT
$586M
| $2.63M | ﹤0.01% |
+133,533
| New | +$2.85M |
|
|
BIG
1284
DELISTED
Big Lots, Inc.
BIG
| $2.61M | ﹤0.01% |
90,092
+51,257
| +132% | +$1.99M |
|
1285
Radian Group
RDN
$4.93B
| $2.6M | ﹤0.01% |
158,925
-6,137
| -4% | -$112K |
|
1286
Element Solutions
ESI
$9.23B
| $2.6M | ﹤0.01% |
251,658
+25,466
| +11% | +$281K |
|
1287
FirstCash
FCFS
$8.78B
| $2.59M | ﹤0.01% |
35,858
+1,260
| +4% | +$100K |
|
|
GTHX
1288
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.59M | ﹤0.01% |
135,277
-14,639
| -10% | -$548K |
|
1289
Allogene Therapeutics
ALLO
$694M
| $2.58M | ﹤0.01% |
+95,822
| New | +$2.55M |
|
1290
Conduent
CNDT
$264M
| $2.58M | ﹤0.01% |
242,381
-22,924
| -9% | -$357K |
|
1291
CNX Resources
CNX
$5.2B
| $2.58M | ﹤0.01% |
225,608
+4,668
| +2% | +$64.4K |
|
|
RPT
1292
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $2.58M | ﹤0.01% |
215,577
-506
| -0.2% | -$6.68K |
|
1293
Core Laboratories
CLB
$521M
| $2.56M | ﹤0.01% |
42,958
-3,586
| -8% | -$309K |
|
1294
Selective Insurance
SIGI
$5.73B
| $2.56M | ﹤0.01% |
41,967
+1,473
| +4% | +$91.7K |
|
|
TECX
1295
Tectonic Therapeutic
TECX
$606M
| $2.56M | ﹤0.01% |
12,795
+2,589
| +25% | +$789K |
|
1296
CNO Financial Group
CNO
$5.1B
| $2.55M | ﹤0.01% |
171,622
+4,608
| +3% | +$84K |
|
1297
The GEO Group
GEO
$4.04B
| $2.54M | ﹤0.01% |
129,168
+2,680
| +2% | +$60.8K |
|
1298
Adient
ADNT
$1.5B
| $2.54M | ﹤0.01% |
168,920
+29,733
| +21% | +$769K |
|
|
CMD
1299
DELISTED
Cantel Medical Corporation
CMD
| $2.54M | ﹤0.01% |
34,156
-1,727
| -5% | -$143K |
|
1300
Hancock Whitney
HWC
$6.24B
| $2.54M | ﹤0.01% |
73,313
+1,731
| +2% | +$70.1K |
|
Similar funds
UBS AM's Q4 2018 Portfolio in Review
As of Q4 2018, UBS AM held 2,899 positions worth $116B, down 14% from $135B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS AM's Q4 2018 filing shows 140 new, 1,359 increased, 845 reduced and 130 closed positions. Its largest new stake was Linde: 1,823,057 shares worth $284M. The largest sale was Aetna Inc, an estimated $339M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2018 buy was Linde: 1,823,057 shares worth $284M.
- UBS AM added most to iShares US Treasury Bond ETF in Q4 2018, an estimated $215M increase.
- UBS AM's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $182M.
- UBS AM fully exited Aetna Inc in Q4 2018, selling an estimated $339M.
- UBS AM's ten largest holdings make up 17% of its $116B portfolio in Q4 2018.
- UBS AM opened 140 new positions and closed 130 in Q4 2018.
- UBS AM's portfolio value fell 14% quarter-over-quarter to $116B.
Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.